161 related articles for article (PubMed ID: 26412148)
1. Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells.
Kim SH; Ryu HG; Lee J; Shin J; Harikishore A; Jung HY; Kim YS; Lyu HN; Oh E; Baek NI; Choi KY; Yoon HS; Kim KT
Sci Rep; 2015 Sep; 5():14570. PubMed ID: 26412148
[TBL] [Abstract][Full Text] [Related]
2. Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response.
Salzano M; Vázquez-Cedeira M; Sanz-García M; Valbuena A; Blanco S; Fernández IF; Lazo PA
Oncotarget; 2014 Apr; 5(7):1770-8. PubMed ID: 24731990
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway.
Liu T; Zuo L; Guo D; Chai X; Xu J; Cui Z; Wang Z; Hou C
Biomed Pharmacother; 2019 Dec; 120():109483. PubMed ID: 31629252
[TBL] [Abstract][Full Text] [Related]
4. Obtusilactone B from Machilus Thunbergii targets barrier-to-autointegration factor to treat cancer.
Kim W; Lyu HN; Kwon HS; Kim YS; Lee KH; Kim DY; Chakraborty G; Choi KY; Yoon HS; Kim KT
Mol Pharmacol; 2013 Feb; 83(2):367-76. PubMed ID: 23150487
[TBL] [Abstract][Full Text] [Related]
5. Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model.
Shih WL; Yu FL; Chang CD; Liao MH; Wu HY; Lin PY
Mol Carcinog; 2013 Oct; 52(10):800-12. PubMed ID: 22549898
[TBL] [Abstract][Full Text] [Related]
6. Luteolin suppresses cancer cell proliferation by targeting vaccinia-related kinase 1.
Kim YS; Kim SH; Shin J; Harikishore A; Lim JK; Jung Y; Lyu HN; Baek NI; Choi KY; Yoon HS; Kim KT
PLoS One; 2014; 9(10):e109655. PubMed ID: 25310002
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of human Vaccinia-Related Kinases (VRK) bound to small-molecule inhibitors identifies different P-loop conformations.
Couñago RM; Allerston CK; Savitsky P; Azevedo H; Godoi PH; Wells CI; Mascarello A; de Souza Gama FH; Massirer KB; Zuercher WJ; Guimarães CRW; Gileadi O
Sci Rep; 2017 Aug; 7(1):7501. PubMed ID: 28790404
[TBL] [Abstract][Full Text] [Related]
8. NMR solution structure of human vaccinia-related kinase 1 (VRK1) reveals the C-terminal tail essential for its structural stability and autocatalytic activity.
Shin J; Chakraborty G; Bharatham N; Kang C; Tochio N; Koshiba S; Kigawa T; Kim W; Kim KT; Yoon HS
J Biol Chem; 2011 Jun; 286(25):22131-8. PubMed ID: 21543316
[TBL] [Abstract][Full Text] [Related]
9. VRK1 interacts with p53 forming a basal complex that is activated by UV-induced DNA damage.
López-Sánchez I; Valbuena A; Vázquez-Cedeira M; Khadake J; Sanz-García M; Carrillo-Jiménez A; Lazo PA
FEBS Lett; 2014 Mar; 588(5):692-700. PubMed ID: 24492002
[TBL] [Abstract][Full Text] [Related]
10. Backbone ¹H, ¹³C and ¹⁵N resonance assignments of human vaccinia-related kinase 1 (VRK1).
Shin J; Chakraborty G; Yoon HS
Biomol NMR Assign; 2014 Apr; 8(1):29-31. PubMed ID: 23212441
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of human vaccinia-related kinase 1 in complex with AMP-PNP, a non-hydrolyzable ATP analog.
Ngow YS; Rajan S; Ye H; Yoon HS
Protein Sci; 2019 Mar; 28(3):524-532. PubMed ID: 30461091
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cell proliferation, invasion and migration by ursolic acid in human lung cancer cell lines.
Huang CY; Lin CY; Tsai CW; Yin MC
Toxicol In Vitro; 2011 Oct; 25(7):1274-80. PubMed ID: 21539908
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomas.
Valbuena A; Suárez-Gauthier A; López-Rios F; López-Encuentra A; Blanco S; Fernández PL; Sánchez-Céspedes M; Lazo PA
Lung Cancer; 2007 Dec; 58(3):303-9. PubMed ID: 17689819
[TBL] [Abstract][Full Text] [Related]
14. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells.
Zheng QY; Jin FS; Yao C; Zhang T; Zhang GH; Ai X
Biochem Biophys Res Commun; 2012 Mar; 419(4):741-7. PubMed ID: 22387548
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid inhibits the growth of colon cancer-initiating cells by targeting STAT3.
Wang W; Zhao C; Jou D; Lü J; Zhang C; Lin L; Lin J
Anticancer Res; 2013 Oct; 33(10):4279-84. PubMed ID: 24122993
[TBL] [Abstract][Full Text] [Related]
17. Ursolic acid induces PC-3 cell apoptosis via activation of JNK and inhibition of Akt pathways in vitro.
Zhang Y; Kong C; Zeng Y; Wang L; Li Z; Wang H; Xu C; Sun Y
Mol Carcinog; 2010 Apr; 49(4):374-85. PubMed ID: 20146252
[TBL] [Abstract][Full Text] [Related]
18. Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor.
Yang L; Liu X; Lu Z; Yuet-Wa Chan J; Zhou L; Fung KP; Wu P; Wu S
Cancer Lett; 2010 Dec; 298(1):128-38. PubMed ID: 20630652
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory Effect of Ursolic Acid on the Migration and Invasion of Doxorubicin-Resistant Breast Cancer.
Zong L; Cheng G; Zhao J; Zhuang X; Zheng Z; Liu Z; Song F
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209071
[TBL] [Abstract][Full Text] [Related]
20. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
